This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Arena Pharmaceuticals, Inc., Other. Active years: 2025.
Company Filing History:
1 out of 218 
1 out of 834,453 Years Active: 2025
Title: Lucie H Clapp: Innovator in Pulmonary Arterial Hypertension Treatment
Introduction
Lucie H Clapp is a notable inventor based in London, GB. She has made significant contributions to the field of medicine, particularly in the treatment of pulmonary arterial hypertension (PAH). Her innovative approaches have the potential to improve patient outcomes and enhance therapeutic efficacy.
Latest Patents
Lucie H Clapp holds a patent for "Methods of treating PAH with combinations of ralinepag and other agents." This patent encompasses combinations of ralinepag with a cGMP-elevating agent or prostanoid such as riociguat, treprostinil, or iloprost for treating PAH. The disclosed combination therapy provides advantages such as improved efficacy, improved safety, and reduced doses and/or frequency of the involved agents. In some embodiments, the clinical effectiveness of a reduced dose combination is additive or synergistic compared to that provided by the corresponding monotherapies.
Career Highlights
Throughout her career, Lucie has worked with various organizations, including Arena Pharmaceuticals, Inc. Her work has focused on developing innovative treatments that address critical health issues, particularly in the realm of cardiovascular diseases.
Collaborations
Lucie has collaborated with notable professionals in her field, including Dominic P Behan and John W Adams. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Lucie H Clapp is a pioneering inventor whose work in the treatment of pulmonary arterial hypertension showcases her commitment to improving healthcare. Her innovative patent and collaborations highlight her significant impact in the medical field.